ChartRow logo
ChartRow
Stocks and ETFs
Sign in
REGN
Regeneron Pharmaceuticals Inc.Stock · Healthcare
$654.27+$29.55 (+4.73%)as of market close, Jul 2, 2026
CompareLLYUNHJNJABBVMRKABT

How Regeneron Pharmaceuticals makes money

Fiscal year

How does Regeneron Pharmaceuticals make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year. Straight from SEC filings.

Regeneron Pharmaceuticals Inc. · FY2025 · year ended 2025-12-31
Revenue$14.3BGross profit$14.3B · 100%Cost of revenue$0 · 0%Operating income$3.6B · 25%Operating expenses$10.8B · 75%R&D$5.9B · 41%SG&A$2.7B · 19%Other opex$2.2B · 15%Pre-tax income$5.2B · 36%Other income$1.7B · 12%Net income$4.5B · 31%Income tax$726M · 5%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.